The NTM Lung Disease Treatment Guidelines were developed by a panel of experts carefully selected by leading international respiratory medicine and infectious disease societies, including the American Thoracic Society (ATS), European Respiratory Society (ERS), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Infectious Diseases Society of America (IDSA). The Guidelines are intended for use by healthcare professionals who care for patients with NTM lung disease, including those that specialize in infectious and pulmonary diseases.